Clinical Trial Update: A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients [Phase 1, Phase 2]

View source ↗

Summary

This update describes an early-phase study to evaluate the safety and tolerability of the investigational drug TR399 in healthy volunteers and men with erectile…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• TR399

Snippet

Sponsor: Tritech Biopharmaceuticals Co., Ltd. | Conditions: Erectile Dysfunction | Phase 1, Phase 2 | Status: UNKNOWN